Cencora, a global pharmaceutical solutions company, completed the acquisition of a 85% stake in Retina Consultants of America, an ophthalmology and retina services provider, from Webster Equity Partners, a private equity firm, for $4.6bn. You can submit deals you were involved with here: https://lnkd.in/d_Firwmh “We are pleased to enter our next phase of growth with the support of a leading global pharmaceutical solutions organization. With additional resources to support the continued execution of our growth strategy, we will be better positioned to continue expanding our physician network and enhancing the quality of care we provide,” Robert Grabow, Retina Consultants of America Chief Executive Officer. Retina Consultants of America (led by Robert Grabow, Robert Diamond and David Brown) was advised by Goldman Sachs, Rothschild & Co, Goodwin and Reed Smith LLP. Cencora (led by Robert Mauch, James F. Cleary, François Mandeville and Elizabeth Campbell) was advised by Lazard, Freshfields (led by Damien Zoubek and Joshua Ayal), Morgan, Lewis & Bockius LLP (led by Andrew Budreika), Sidley Austin LLP and FGS Global (led by Kirsti Hastings). #MergersAcquisitionsDiversitures #HealthCare #PrivateEquity
